Frontlight ResearchEarly access
Trial site
Ospedale Galeazzi S.p.A.
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease2 trials
- Osteoarthritis2 trials
- Polymyalgia rheumatica2 trials
- Aortic stenosis1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Giant cell arteritis1 trial
- Gout1 trial
- Obesity1 trial
- Osteoporosis1 trial
- Sjögren's disease1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Completed4 trials
- Not yet recruiting3 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals4 trials
- Heart Care Foundation1 trial
- Horizon Therapeutics Ireland Designated Activity Company1 trial
- LG Chem1 trial
- Novo Nordisk A/S1 trial
- and 3 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Osteoarthritis2 recruiting
- Aortic stenosis1 recruiting
- Coronary artery disease1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Obesity1 recruiting
- Osteoporosis1 recruiting
Closed trials
Completed
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Active, not recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026